Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational ...

Discover comprehensive details about Mebendazole, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

A recent study finds the use of an antiparasitic drug mebendazole to be effective in treating brain tumors, reveals study. Brain tumors are a mass or growth of abnormal cells in the brain.

Prognostic impact of baseline LDH on survival independent of tumor burden in advanced melanoma: Results of phase III trial of oblimersen-dacarbazine (OBL-DTIC) vs DTIC No significant financial ...

As the third-most lethal cancer in the United States, with only a 1% five-year survival rate for people with its most aggressive form, pancreatic cancer has long been a target of researchers who ...

Cancer researchers are testing whether a generic drug that has been used for more than 40 years to treat parasitic infections may also help fight cancer. The tests of mebendazole are part of a growing ...

A new study is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. Marc Symons, PhD, professor in The Feinstein ...

NEW YORK, August 6, 2008 – Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, ...